{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T22:42:23Z","timestamp":1794609743496,"version":"4.9.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T00:00:00Z","timestamp":1702857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T00:00:00Z","timestamp":1702857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["VI.Veni.192.095."],"award-info":[{"award-number":["VI.Veni.192.095."]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Overexpression of NorA efflux pumps plays a pivotal role in the multidrug-resistance mechanism in <jats:italic>S. aureus<\/jats:italic>. Here, we investigated the activities of prenylated isoflavonoids, present in the legume plant family (Fabaceae), as natural efflux pump inhibitors (EPIs) in fluoroquinolone-resistant <jats:italic>S. aureus<\/jats:italic>. We found that four prenylated isoflavonoids, namely neobavaisoflavone, glabrene, glyceollin I, and glyceollin III, showed efflux pump inhibition in the <jats:italic>norA <\/jats:italic>overexpressing <jats:italic>S. aureus<\/jats:italic>. At sub-inhibitory concentrations, neobavaisoflavone (6.25\u00a0\u00b5g\/mL, 19\u00a0\u00b5M) and glabrene (12.5\u00a0\u00b5g\/mL, 39\u00a0\u00b5M), showed up to 6 times more Eth accumulation in <jats:italic>norA<\/jats:italic> overexpressing <jats:italic>S. aureus<\/jats:italic> than in the control. In addition, these two compounds boosted the MIC of fluoroquinolones up to eightfold. No fluoroquinolone potentiation was observed with these isoflavonoids in the <jats:italic>norA<\/jats:italic> knockout strain, indicating NorA as the main target of these potential EPIs. In comparison to the reported NorA EPI reserpine, neobavaisoflavone showed similar potentiation of fluoroquinolone activity at 10\u00a0\u00b5M, higher Eth accumulation, and less cytotoxicity. Neobavaisoflavone and glabrene did not exhibit membrane permeabilization effects or cytotoxicity on Caco-2 cells. In conclusion, our findings suggest that the prenylated isoflavonoids neobavaisoflavone and glabrene are promising phytochemicals that could be developed as antimicrobials and resistance-modifying agents to treat fluoroquinolone-resistant <jats:italic>S. aureus<\/jats:italic> strains.<\/jats:p>","DOI":"10.1038\/s41598-023-48992-8","type":"journal-article","created":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T17:02:50Z","timestamp":1702918970000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Prenylated isoflavonoids from Fabaceae against the NorA efflux pump in Staphylococcus aureus"],"prefix":"10.1038","volume":"13","author":[{"given":"Marina","family":"Ika Irianti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Vincken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"van Dinteren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"ter Beest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaas Martinus","family":"Pos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Araya-Cloutier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,18]]},"reference":[{"key":"48992_CR1","doi-asserted-by":"publisher","first-page":"778","DOI":"10.3390\/antibiotics10070778","volume":"10","author":"A Castro-Lopes","year":"2021","unstructured":"Castro-Lopes, A. et al. Increase of antimicrobial consumption in a tertiary care hospital during the first phase of the COVID-19 pandemic. Antibiotics 10, 778. https:\/\/doi.org\/10.3390\/antibiotics10070778 (2021).","journal-title":"Antibiotics"},{"key":"48992_CR2","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.mib.2019.10.008","volume":"51","author":"MI Hutchings","year":"2019","unstructured":"Hutchings, M. I., Truman, A. W. & Wilkinson, B. Antibiotics: Past, present and future. Curr. Opin. Microbiol. 51, 72\u201380. https:\/\/doi.org\/10.1016\/j.mib.2019.10.008 (2019).","journal-title":"Curr. Opin. Microbiol."},{"key":"48992_CR3","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1093\/jac\/dkv175","volume":"70","author":"LJ Piddock","year":"2015","unstructured":"Piddock, L. J. Teixobactin, the first of a new class of antibiotics discovered by iChip technology?. J. Antimicrob. Chemother. 70, 2679\u20132680. https:\/\/doi.org\/10.1093\/jac\/dkv175 (2015).","journal-title":"J. Antimicrob. Chemother."},{"key":"48992_CR4","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1039\/b212695h","volume":"21","author":"S Gibbons","year":"2004","unstructured":"Gibbons, S. Anti-staphylococcal plant natural products. Nat. Prod. Rep. 21, 263\u2013277. https:\/\/doi.org\/10.1039\/b212695h (2004).","journal-title":"Nat. Prod. Rep."},{"key":"48992_CR5","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1039\/c2np20035j","volume":"29","author":"AC Abreu","year":"2012","unstructured":"Abreu, A. C., McBain, A. J. & Simoes, M. Plants as sources of new antimicrobials and resistance-modifying agents. Nat. Prod. Rep. 29, 1007\u20131021. https:\/\/doi.org\/10.1039\/c2np20035j (2012).","journal-title":"Nat. Prod. Rep."},{"key":"48992_CR6","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1001\/archinte.165.15.1756","volume":"165","author":"GA Noskin","year":"2005","unstructured":"Noskin, G. A. et al. The burden of Staphylococcus aureus infections on hospitals in the United States: An analysis of the 2000 and 2001 Nationwide Inpatient Sample Database. Arch. Intern. Med. 165, 1756\u20131761. https:\/\/doi.org\/10.1001\/archinte.165.15.1756 (2005).","journal-title":"Arch. Intern. Med."},{"key":"48992_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004564","volume":"11","author":"TC Smith","year":"2015","unstructured":"Smith, T. C. Livestock-associated Staphylococcus aureus: The United States experience. PLoS Pathog. 11, e1004564. https:\/\/doi.org\/10.1371\/journal.ppat.1004564 (2015).","journal-title":"PLoS Pathog."},{"key":"48992_CR8","unstructured":"Centers for Disease, C. & Prevention. Staphylococcus aureus resistant to vancomycin. MMWR Morb. Mortal. Wkly. Rep. 51, 565\u2013567 (2002)"},{"key":"48992_CR9","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1128\/AAC.35.9.1911","volume":"35","author":"N Harnett","year":"1991","unstructured":"Harnett, N., Brown, S. & Krishnan, C. Emergence of quinolone resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in Ontario, Canada. Antimicrob. Agents Chemother. 35, 1911\u20131913. https:\/\/doi.org\/10.1128\/AAC.35.9.1911 (1991).","journal-title":"Antimicrob. Agents Chemother."},{"key":"48992_CR10","doi-asserted-by":"publisher","first-page":"339","DOI":"10.7326\/0003-4819-97-3-339","volume":"97","author":"LD Sabath","year":"1982","unstructured":"Sabath, L. D. Mechanisms of resistance to beta-lactam antibiotics in strains of Staphylococcus aureus. Ann. Intern. Med. 97, 339\u2013344. https:\/\/doi.org\/10.7326\/0003-4819-97-3-339 (1982).","journal-title":"Ann. Intern. Med."},{"key":"48992_CR11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0140-6736(01)05410-1","volume":"358","author":"S Tsiodras","year":"2001","unstructured":"Tsiodras, S. et al. Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 358, 207\u2013208. https:\/\/doi.org\/10.1016\/S0140-6736(01)05410-1 (2001).","journal-title":"Lancet"},{"key":"48992_CR12","doi-asserted-by":"publisher","first-page":"5854","DOI":"10.1128\/jb.173.18.5854-5860.1991","volume":"173","author":"M Trucksis","year":"1991","unstructured":"Trucksis, M., Wolfson, J. S. & Hooper, D. C. A novel locus conferring fluoroquinolone resistance in Staphylococcus aureus. J. Bacteriol. 173, 5854\u20135860. https:\/\/doi.org\/10.1128\/jb.173.18.5854-5860.1991 (1991).","journal-title":"J. Bacteriol."},{"key":"48992_CR13","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1128\/aac.37.5.1086","volume":"37","author":"GW Kaatz","year":"1993","unstructured":"Kaatz, G. W., Seo, S. M. & Ruble, C. A. Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 37, 1086\u20131094. https:\/\/doi.org\/10.1128\/aac.37.5.1086 (1993).","journal-title":"Antimicrob. Agents Chemother."},{"key":"48992_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.drup.2016.06.007","volume":"28","author":"S Hernando-Amado","year":"2016","unstructured":"Hernando-Amado, S. et al. Multidrug efflux pumps as main players in intrinsic and acquired resistance to antimicrobials. Drug Resist. Updat. 28, 13\u201327. https:\/\/doi.org\/10.1016\/j.drup.2016.06.007 (2016).","journal-title":"Drug Resist. Updat."},{"key":"48992_CR15","doi-asserted-by":"publisher","first-page":"5070","DOI":"10.1128\/AAC.01058-10","volume":"54","author":"D Patel","year":"2010","unstructured":"Patel, D., Kosmidis, C., Seo, S. M. & Kaatz, G. W. Ethidium bromide MIC screening for enhanced efflux pump gene expression or efflux activity in Staphylococcus aureus. Antimicrob. Agents Chemother. 54, 5070\u20135073. https:\/\/doi.org\/10.1128\/AAC.01058-10 (2010).","journal-title":"Antimicrob. Agents Chemother."},{"key":"48992_CR16","doi-asserted-by":"publisher","first-page":"6996","DOI":"10.3390\/molecules26226996","volume":"26","author":"G Cernicchi","year":"2021","unstructured":"Cernicchi, G., Felicetti, T. & Sabatini, S. Microbial efflux pump inhibitors: A journey around quinoline and indole derivatives. Molecules 26, 6996. https:\/\/doi.org\/10.3390\/molecules26226996 (2021).","journal-title":"Molecules"},{"key":"48992_CR17","doi-asserted-by":"publisher","first-page":"7376","DOI":"10.1128\/AEM.01310-08","volume":"74","author":"M Kvist","year":"2008","unstructured":"Kvist, M., Hancock, V. & Klemm, P. Inactivation of efflux pumps abolishes bacterial biofilm formation. Appl. Environ. Microbiol. 74, 7376\u20137382. https:\/\/doi.org\/10.1128\/AEM.01310-08 (2008).","journal-title":"Appl. Environ. Microbiol."},{"key":"48992_CR18","doi-asserted-by":"publisher","first-page":"37007","DOI":"10.1039\/C7RA03859C","volume":"7","author":"S Sabatini","year":"2017","unstructured":"Sabatini, S. et al. Investigation on the effect of known potent S. aureus NorA efflux pump inhibitors on the staphylococcal biofilm formation. RSC Adv. 7, 37007\u201337014. https:\/\/doi.org\/10.1039\/C7RA03859C (2017).","journal-title":"RSC Adv."},{"key":"48992_CR19","doi-asserted-by":"publisher","first-page":"3970","DOI":"10.1038\/s41467-020-17735-y","volume":"11","author":"A Papkou","year":"2020","unstructured":"Papkou, A., Hedge, J., Kapel, N., Young, B. & MacLean, R. C. Efflux pump activity potentiates the evolution of antibiotic resistance across S. aureus isolates. Nat. Commun. 11, 3970. https:\/\/doi.org\/10.1038\/s41467-020-17735-y (2020).","journal-title":"Nat. Commun."},{"key":"48992_CR20","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3389\/fmicb.2015.00421","volume":"6","author":"TJ Opperman","year":"2015","unstructured":"Opperman, T. J. & Nguyen, S. T. Recent advances toward a molecular mechanism of efflux pump inhibition. Front. Microbiol. 6, 421. https:\/\/doi.org\/10.3389\/fmicb.2015.00421 (2015).","journal-title":"Front. Microbiol."},{"key":"48992_CR21","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1093\/jac\/42.6.807","volume":"42","author":"FJ Schmitz","year":"1998","unstructured":"Schmitz, F. J. et al. The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus. J. Antimicrob. Chemother. 42, 807\u2013810. https:\/\/doi.org\/10.1093\/jac\/42.6.807 (1998).","journal-title":"J. Antimicrob. Chemother."},{"key":"48992_CR22","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1073\/pnas.030540597","volume":"97","author":"FR Stermitz","year":"2000","unstructured":"Stermitz, F. R., Lorenz, P., Tawara, J. N., Zenewicz, L. A. & Lewis, K. Synergy in a medicinal plant: Antimicrobial action of berberine potentiated by 5 \u2019-methoxyhydnocarpin, a multidrug pump inhibitor. Proc. Natl. Acad. Sci. USA 97, 1433\u20131437 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"48992_CR23","doi-asserted-by":"publisher","first-page":"4480","DOI":"10.1128\/AAC.00216-07","volume":"51","author":"EC Smith","year":"2007","unstructured":"Smith, E. C. et al. The phenolic diterpene totarol inhibits multidrug efflux pump activity in Staphylococcus aureus. Antimicrob. Agents Chemother. 51, 4480\u20134483. https:\/\/doi.org\/10.1128\/AAC.00216-07 (2007).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"12","key":"48992_CR24","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1055\/s-2004-835860","volume":"70","author":"S Gibbons","year":"2004","unstructured":"Gibbons, S., Moser, E. & Kaatz, G. W. Catechin gallates inhibit multidrug resistance (MDR) in Staphylococcus aureus. Planta Med. 70(12), 1240\u20131242. https:\/\/doi.org\/10.1055\/s-2004-835860 (2004).","journal-title":"Planta Med."},{"key":"48992_CR25","doi-asserted-by":"publisher","first-page":"6904","DOI":"10.3390\/molecules26226904","volume":"26","author":"M Waditzer","year":"2021","unstructured":"Waditzer, M. & Bucar, F. Flavonoids as inhibitors of bacterial efflux pumps. Molecules 26, 6904. https:\/\/doi.org\/10.3390\/molecules26226904 (2021).","journal-title":"Molecules"},{"key":"48992_CR26","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1039\/C4MD00196F","volume":"5","author":"P Joshi","year":"2014","unstructured":"Joshi, P. et al. Osthol and curcumin as inhibitors of human Pgp and multidrug efflux pumps of Staphylococcus aureus: Reversing the resistance against frontline antibacterial drugs. Medchemcomm 5, 1540\u20131547. https:\/\/doi.org\/10.1039\/C4MD00196F (2014).","journal-title":"Medchemcomm"},{"key":"48992_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.106098","volume":"56","author":"ZL Sun","year":"2020","unstructured":"Sun, Z. L. et al. Synergism of sophoraflavanone G with norfloxacin against effluxing antibiotic-resistant Staphylococcus aureus. Int. J. Antimicrob. Agents 56, 106098. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.106098 (2020).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"48992_CR28","doi-asserted-by":"crossref","unstructured":"Popa, D.-S. & Rusu, M. E. Isoflavones: Vegetable sources, biological activity, and analytical methods for their assessment. (2017).","DOI":"10.5772\/66531"},{"key":"48992_CR29","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2174\/1568026622666220117104709","volume":"18","author":"I G\u00f3rniak","year":"2019","unstructured":"G\u00f3rniak, I., Bartoszewski, R. & Kr\u00f3liczewski, J. Comprehensive review of antimicrobial activities of plant flavonoids. Phytochem. Rev. 18, 241\u2013272. https:\/\/doi.org\/10.2174\/1568026622666220117104709 (2019).","journal-title":"Phytochem. Rev."},{"key":"48992_CR30","unstructured":"Araya-Cloutier, C. Antibacterial prenylated isoflavonoids and stilbenoids: quantitative structure-activity relationships and mode of action, Wageningen University and Research (2017)."},{"key":"48992_CR31","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/j.phytochem.2009.08.023","volume":"70","author":"K Yazaki","year":"2009","unstructured":"Yazaki, K., Sasaki, K. & Tsurumaru, Y. Prenylation of aromatic compounds, a key diversification of plant secondary metabolites. Phytochemistry 70, 1739\u20131745. https:\/\/doi.org\/10.1016\/j.phytochem.2009.08.023 (2009).","journal-title":"Phytochemistry"},{"key":"48992_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.phytochem.2020.112496","volume":"179","author":"S Kalli","year":"2020","unstructured":"Kalli, S., Araya-Cloutier, C., de Bruijn, W. J. C., Chapman, J. & Vincken, J. P. Induction of promising antibacterial prenylated isoflavonoids from different subclasses by sequential elicitation of soybean. Phytochemistry 179, 112496. https:\/\/doi.org\/10.1016\/j.phytochem.2020.112496 (2020).","journal-title":"Phytochemistry"},{"key":"48992_CR33","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.3390\/ijms20164041","volume":"20","author":"D Palazzotti","year":"2019","unstructured":"Palazzotti, D. et al. Deciphering the molecular recognition mechanism of multidrug resistance Staphylococcus aureus NorA efflux pump using a supervised molecular dynamics approach. Int. J. Mol. Sci. 20, 4041. https:\/\/doi.org\/10.3390\/ijms20164041 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"48992_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-27545-4","volume":"8","author":"C Araya-Cloutier","year":"2018","unstructured":"Araya-Cloutier, C. et al. QSAR-based molecular signatures of prenylated (iso)flavonoids underlying antimicrobial potency against and membrane-disruption in Gram positive and Gram negative bacteria. Sci. Rep. 8, 1\u201314. https:\/\/doi.org\/10.1038\/s41598-018-27545-4 (2018).","journal-title":"Sci. Rep."},{"key":"48992_CR35","unstructured":"Ahad, N. A. & Yahaya, S. S. S. in AIP Conference proceedings. 888\u2013893 (American Institute of Physics)."},{"key":"48992_CR36","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/s0924-8579(02)00162-0","volume":"20","author":"CT Price","year":"2002","unstructured":"Price, C. T., Kaatz, G. W. & Gustafson, J. The multidrug efflux pump NorA is not required for salicylate-induced reduction in drug accumulation by Staphylococcus aureus. Int. J. Antimicrob. Agents 20, 206\u2013213. https:\/\/doi.org\/10.1016\/s0924-8579(02)00162-0 (2002).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"48992_CR37","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1128\/AAC.37.1.128","volume":"37","author":"AA Neyfakh","year":"1993","unstructured":"Neyfakh, A. A., Borsch, C. & Kaatz, G. Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter. Antimicrob. Agents Chemother. 37, 128\u2013129. https:\/\/doi.org\/10.1128\/AAC.37.1.128 (1993).","journal-title":"Antimicrob. Agents Chemother."},{"key":"48992_CR38","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/00001813-199508000-00005","volume":"6","author":"WA Dengler","year":"1995","unstructured":"Dengler, W. A., Schulte, J., Berger, D. P., Mertelsmann, R. & Fiebig, H. H. Development of a propidium iodide fluorescence assay for proliferation and cytotoxicity assays. Anticancer Drugs 6, 522\u2013532. https:\/\/doi.org\/10.1097\/00001813-199508000-00005 (1995).","journal-title":"Anticancer Drugs"},{"key":"48992_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12866-015-0376-x","volume":"15","author":"P Stiefel","year":"2015","unstructured":"Stiefel, P., Schmidt-Emrich, S., Maniura-Weber, K. & Ren, Q. Critical aspects of using bacterial cell viability assays with the fluorophores SYTO9 and propidium iodide. BMC Microbiol. 15, 1\u20139 (2015).","journal-title":"BMC Microbiol."},{"key":"48992_CR40","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.mimet.2017.09.011","volume":"142","author":"C Kirchhoff","year":"2017","unstructured":"Kirchhoff, C. & Cypionka, H. Propidium ion enters viable cells with high membrane potential during live-dead staining. J. Microbiol. Methods 142, 79\u201382. https:\/\/doi.org\/10.1016\/j.mimet.2017.09.011 (2017).","journal-title":"J. Microbiol. Methods"},{"key":"48992_CR41","doi-asserted-by":"publisher","first-page":"e00840","DOI":"10.1128\/mBio.00840-16","volume":"7","author":"JM Blair","year":"2016","unstructured":"Blair, J. M. & Piddock, L. J. How to measure export via bacterial multidrug resistance efflux pumps. MBio 7, e00840-e1816. https:\/\/doi.org\/10.1128\/mBio.00840-16 (2016).","journal-title":"MBio"},{"key":"48992_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1754-1611-3-18","volume":"3","author":"L Paix\u00e3o","year":"2009","unstructured":"Paix\u00e3o, L. et al. Fluorometric determination of ethidium bromide efflux kinetics in Escherichia coli. J. Biol. Eng. 3, 1\u201313. https:\/\/doi.org\/10.1186\/1754-1611-3-18 (2009).","journal-title":"J. Biol. Eng."},{"key":"48992_CR43","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1128\/AAC.45.1.105-116.2001","volume":"45","author":"O Lomovskaya","year":"2001","unstructured":"Lomovskaya, O. et al. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob. Agents Chemother. 45, 105\u2013116. https:\/\/doi.org\/10.1128\/AAC.45.1.105-116.2001 (2001).","journal-title":"Antimicrob. Agents Chemother."},{"key":"48992_CR44","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1128\/AAC.01866-13","volume":"58","author":"TJ Opperman","year":"2014","unstructured":"Opperman, T. J. et al. Characterization of a Novel Pyranopyridine Inhibitor of the AcrAB efflux pump of Escherichia coli. Antimicrob. Agents Chemother. 58, 722\u2013733. https:\/\/doi.org\/10.1128\/AAC.01866-13 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"48992_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-03716-7","volume":"7","author":"AC Abreu","year":"2017","unstructured":"Abreu, A. C. et al. Looking to nature for a new concept in antimicrobial treatments: Isoflavonoids from Cytisus striatus as antibiotic adjuvants against MRSA. Sci. Rep. 7, 1\u201316. https:\/\/doi.org\/10.1038\/s41598-017-03716-7 (2017).","journal-title":"Sci. Rep."},{"key":"48992_CR46","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/s0924-8579(03)00218-8","volume":"22","author":"E Reynolds","year":"2003","unstructured":"Reynolds, E., Ross, J. I. & Cove, J. H. Msr(A) and related macrolide\/streptogramin resistance determinants: Incomplete transporters?. Int. J. Antimicrob. Agents 22, 228\u2013236. https:\/\/doi.org\/10.1016\/s0924-8579(03)00218-8 (2003).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"48992_CR47","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1080\/07853890701195262","volume":"39","author":"K Poole","year":"2007","unstructured":"Poole, K. Efflux pumps as antimicrobial resistance mechanisms. Ann. Med. 39, 162\u2013176. https:\/\/doi.org\/10.1080\/07853890701195262 (2007).","journal-title":"Ann. Med."},{"key":"48992_CR48","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.foodchem.2017.07.074","volume":"240","author":"C Araya-Cloutier","year":"2018","unstructured":"Araya-Cloutier, C., Vincken, J. P., van Ederen, R., den Besten, H. M. W. & Gruppen, H. Rapid membrane permeabilization of Listeria monocytogenes and Escherichia coli induced by antibacterial prenylated phenolic compounds from legumes. Food Chem. 240, 147\u2013155. https:\/\/doi.org\/10.1016\/j.foodchem.2017.07.074 (2018).","journal-title":"Food Chem."},{"key":"48992_CR49","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.phymed.2015.01.002","volume":"22","author":"SA Abdelfatah","year":"2015","unstructured":"Abdelfatah, S. A. & Efferth, T. Cytotoxicity of the indole alkaloid reserpine from Rauwolfia serpentina against drug-resistant tumor cells. Phytomedicine 22, 308\u2013318. https:\/\/doi.org\/10.1016\/j.phymed.2015.01.002 (2015).","journal-title":"Phytomedicine"},{"key":"48992_CR50","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0928-0987(95)00007-Z","volume":"3","author":"A Wikman-Larhed","year":"1995","unstructured":"Wikman-Larhed, A. & Artursson, P. Co-cultures of human intestinal goblet (HT29-H) and absorptive (Caco-2) cells for studies of drug and peptide absorption. Eur. J. Pharm. Sci. 3, 171\u2013183. https:\/\/doi.org\/10.1016\/0928-0987(95)00007-Z (1995).","journal-title":"Eur. J. Pharm. Sci."},{"issue":"2","key":"48992_CR51","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1016\/s0928-0987(00)00165-2","volume":"11","author":"M Bertrand","year":"2000","unstructured":"Bertrand, M., Jackson, P. & Walther, B. Rapid assessment of drug metabolism in the drug discovery process. Eur. J. Pharm. Sci. 11(2), S61-72. https:\/\/doi.org\/10.1016\/s0928-0987(00)00165-2 (2000).","journal-title":"Eur. J. Pharm. Sci."},{"key":"48992_CR52","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.tibtech.2018.12.001","volume":"37","author":"JS Dutton","year":"2019","unstructured":"Dutton, J. S., Hinman, S. S., Kim, R., Wang, Y. & Allbritton, N. L. Primary cell-derived intestinal models: Recapitulating physiology. Trends Biotechnol. 37, 744\u2013760. https:\/\/doi.org\/10.1016\/j.tibtech.2018.12.001 (2019).","journal-title":"Trends Biotechnol."},{"key":"48992_CR53","doi-asserted-by":"publisher","first-page":"104542","DOI":"10.1016\/j.isci.2022.104542","volume":"25","author":"Y Takahashi","year":"2022","unstructured":"Takahashi, Y. et al. Organoid-derived intestinal epithelial cells are a suitable model for preclinical toxicology and pharmacokinetic studies. iScience 25, 104542. https:\/\/doi.org\/10.1016\/j.isci.2022.104542 (2022).","journal-title":"iScience"},{"key":"48992_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-92964-9","volume":"11","author":"S Kalli","year":"2022","unstructured":"Kalli, S., Araya-Cloutier, C., Hageman, J. & Vincken, J. Insights into the molecular properties underlying antibacterial activity of prenylated (iso)flavonoids against MRSA. Sci. Rep. 11, 1\u201314. https:\/\/doi.org\/10.1038\/s41598-021-92964-9 (2022).","journal-title":"Sci. Rep."},{"key":"48992_CR55","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1021\/acsomega.7b01759","volume":"3","author":"J Li","year":"2018","unstructured":"Li, J., Beuerman, R. W. & Verma, C. S. Molecular insights into the membrane affinities of model hydrophobes. ACS Omega 3, 2498\u20132507. https:\/\/doi.org\/10.1021\/acsomega.7b01759 (2018).","journal-title":"ACS Omega"},{"key":"48992_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41589-022-00994-9","author":"DN Brawley","year":"2022","unstructured":"Brawley, D. N. et al. Structural basis for inhibition of the drug efflux pump NorA from Staphylococcus aureus. Nat. Chem. Biol. https:\/\/doi.org\/10.1038\/s41589-022-00994-9 (2022).","journal-title":"Nat. Chem. Biol."},{"key":"48992_CR57","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1002\/cbic.201500343","volume":"16","author":"MG Van de Schans","year":"2015","unstructured":"Van de Schans, M. G. et al. Involvement of a hydrophobic pocket and helix 11 in determining the modes of action of prenylated flavonoids and isoflavonoids in the human estrogen receptor. Chembiochem 16, 2668\u20132677. https:\/\/doi.org\/10.1002\/cbic.201500343 (2015).","journal-title":"Chembiochem"},{"key":"48992_CR58","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jsbmb.2015.11.020","volume":"156","author":"MG Van De Schans","year":"2016","unstructured":"Van De Schans, M. G. et al. Glyceollins and dehydroglyceollins isolated from soybean act as SERMs and ER subtype-selective phytoestrogens. J. Steroid Biochem. Mol. Biol. 156, 53\u201363. https:\/\/doi.org\/10.1016\/j.jsbmb.2015.11.020 (2016).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"48992_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.lwt.2020.109843","volume":"134","author":"S Andini","year":"2020","unstructured":"Andini, S., Araya-Cloutier, C., Waardenburg, L., den Besten, H. M. W. & Vincken, J. P. The interplay between antimicrobial activity and reactivity of isothiocyanates. Lwt-Food Sci. Technol. 134, 109843. https:\/\/doi.org\/10.1016\/j.lwt.2020.109843 (2020).","journal-title":"Lwt-Food Sci. Technol."},{"key":"48992_CR60","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1093\/jac\/dkq169","volume":"65","author":"NG Coldham","year":"2010","unstructured":"Coldham, N. G., Webber, M., Woodward, M. J. & Piddock, L. J. A 96-well plate fluorescence assay for assessment of cellular permeability and active efflux in Salmonella enterica serovar typhimurium and Escherichia coli. J. Antimicrob. Chemother. 65, 1655\u20131663. https:\/\/doi.org\/10.1093\/jac\/dkq169 (2010).","journal-title":"J. Antimicrob. Chemother."},{"key":"48992_CR61","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.3390\/antibiotics10091075","volume":"10","author":"K \u0160imunovi\u0107","year":"2021","unstructured":"\u0160imunovi\u0107, K. et al. Efflux pump inhibition and resistance modulation in Mycobacterium smegmatis by Peucedanum ostruthium and Its Coumarins. Antibiotics 10, 1075. https:\/\/doi.org\/10.3390\/antibiotics10091075 (2021).","journal-title":"Antibiotics"},{"key":"48992_CR62","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.3389\/fmicb.2019.02762","volume":"10","author":"S Zimmermann","year":"2019","unstructured":"Zimmermann, S. et al. Clinically approved drugs inhibit the Staphylococcus aureus multidrug NorA efflux pump and reduce biofilm formation. Front. Microbiol. 10, 2762. https:\/\/doi.org\/10.3389\/fmicb.2019.02762 (2019).","journal-title":"Front. Microbiol."},{"key":"48992_CR63","doi-asserted-by":"publisher","first-page":"12105","DOI":"10.1039\/D2FO02197H","volume":"13","author":"S van Dinteren","year":"2022","unstructured":"van Dinteren, S. et al. Valorisation of liquorice (Glycyrrhiza) roots: Antimicrobial activity and cytotoxicity of prenylated (iso)flavonoids and chalcones from liquorice spent (G. glabra, G. inflata, and G. uralensis). Food Funct. 13, 12105\u201312120. https:\/\/doi.org\/10.1039\/D2FO02197H (2022).","journal-title":"Food Funct."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-48992-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-48992-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-48992-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T19:09:39Z","timestamp":1703185779000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-48992-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,18]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["48992"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-48992-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,18]]},"assertion":[{"value":"25 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22548"}}